Russia has approved R-Pharm’s drug for the treatment of coronavirus. This medicine can be given to people with mild to moderate symptoms. The company says that this drug will hit the market by next week.
This is the second drug of the Russian Pharma company after Avifavir, which has been allowed as a corona drug after consultation.
What is coronavirus
Both these drugs are based on favipiravir which is given during viral treatment in Japan. Let us tell you that Russia had already claimed to make the Corona vaccine and named the vaccine as Sputnik-V. Russia has also tied up with many companies regarding the vaccine.
R-Pharm says the drug has been approved after the third phase of a clinical trial involving 168 Corona-infected patients. In July, it was approved for hospital treatment. The European health regulator on Friday supported the use of the steroid dexamethasone in the treatment of COVID-19 patients after a study by UK researchers on several thousand patients.
R-Pharm has started negotiating orders from forme companies. A company spokesperson said Corona’s drug supply could decline in the near future. In such a situation, it is necessary to launch the drug in the market.